HAWTHORNE, N.Y.
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter and six months ended September 30, 2018, on Monday, November 5, 2018.
The Company will conduct an earnings call at 8:00 am EST on Tuesday, November 6, 2018, where senior management will discuss the Company’s performance and answer questions from participants.
The earnings release will be accessible on Taro’s website at www.taro.com.
Earnings Call (8:00 am EST on Tuesday, November 6, 2018)
To participate in this conference call, please dial the numbers provided below five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.taro.com. A transcript of this earnings call will also be available on the website.
|
Summary of events |
||||||
| Event | Date and time | Telephone number/ website | ||||
| Earnings release | November 5, 2018 (AMC) | |||||
| Earnings conference call | 8:00 am EST
November 6, 2018 |
Participant Toll-Free Dial-In Number: +1 (844) 421-0601 Participant International Dial-In Number: +1 (716) 247-5800 Conference ID: 2871389
Via audio webcast, details of which will be made available on www.taro.com |
||||
| Replay of conference call | November 6, 2018 to
November 18, 2018 |
+ 1 (855) 859-2056 or +1 (404) 537-3406 Conference ID: 2871389
Via audio webcast playback, details of which will be made available on www.taro.com |
||||
About Taro
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181029005695/en/
CONTACT
Taro Pharmaceutical Industries Ltd.
Mariano A. Balaguer
VP,
CFO
(914) 345-9001
Mariano.Balaguer@taro.com
or
William
J. Coote
AVP, Business Finance, Treasurer and Investor Relations
(914)
345-9001
William.Coote@taro.com
